Provided by Tiger Fintech (Singapore) Pte. Ltd.

Keros Therapeutics, Inc.

14.44
-0.0100-0.07%
Post-market: 14.04-0.3890-2.70%19:10 EDT
Volume:746.63K
Turnover:10.77M
Market Cap:585.72M
PE:-2.89
High:14.60
Open:14.40
Low:14.27
Close:14.45
Loading ...
Mar 25, 2021

Major Issues Report

8-K - Current report
Mar 05, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 17, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 15, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 21, 2020

Major Issues Report

8-K - Current report
Dec 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 17, 2020

Major Issues Report

8-K - Current report
Dec 07, 2020

Major Issues Report

8-K - Current report
Nov 25, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 20, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 17, 2020

Major Issues Report

8-K - Current report
Nov 13, 2020

Major Issues Report

8-K - Current report
Nov 10, 2020

Correspondence

CORRESP [Cover] - Correspondence